Lucy To
Associate
lucy.to@torreyapartners.com
(212) 331-7841
Lucy has been involved in a number of recent financial advisory assignments at Torreya. Lucy was formerly at Cowen and Company in the healthcare investment banking group. Prior to her career in investment banking, she worked at FibroGen, a biotechnology company focused on the discovery, development, and commercialization of therapeutics for fibrosis, anemia, conditions associated with tissue damage or injury, and cancer. Lucy received a B.A. in Finance from Southern Methodist University.
Selected Transaction Experience:
• Columbia Labs, Sale of Progesterone Related Assets to Watson, $107.5 million (pending)
• Teikoku Pharma USA, Acquisition of Travanti Pharma (2009)
• Genentech, Sale to Roche, Advisor to Investor Group in Genentech, $46.8 billion (2009)
• Aradigm, Registered Direct Financing, $4.5 million (2009)
• Introgen Therapeutics, Corporate Restructuring (2008)
• AGI Dermatics, Sale to Estée Lauder (2008)
• Navitas Pharma, Sale to Gilead (2008)
• ProEthic Pharmaceuticals, Sale to Kowa (2008)
• Midlothian Laboratories, Sale to Hi-Tech Pharmacal (2007)
• Genoptix, Initial Public Offering, $80 million (2007)
Lucy is a registered representative with Financial West Group, Torreya’s financing partner.
Copyright © 2010 Torreya Partners LLC. All rights reserved.
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.